Coxsackievirus B3 Infection Early in Pregnancy Induces Congenital Heart Defects Through Suppression of Fetal

Vipul Sharma1, Lisa S Goessling1, Anoop K Brar1

  • 1Division of Pediatric Cardiothoracic Surgery Department of Surgery Washington University School of Medicine St. Louis MO.

Insights

Prenatal Coxsackievirus B3 infection during early gestation can cause congenital heart defects in fetuses. This viral exposure impacts cardiomyocyte proliferation and cardiac development, leading to conditions like ventricular septal defects.

Area of Science:

  • Cardiovascular Research
  • Developmental Biology
  • Virology

Background:

  • Coxsackievirus B (CVB) is a leading cause of viral myocarditis.
  • The coxsackie and adenovirus receptor, targeted by CVB, is highly expressed in the fetal heart.
  • Prenatal CVB3 infection is hypothesized to cause congenital heart defects (CHDs) during critical gestational windows.

Purpose of the Study:

  • To investigate if Coxsackievirus B3 (CVB3) infection during early gestation precipitates congenital heart defects in a mouse model.
  • To determine the critical window of gestation and dose-response relationship for CVB3-induced CHDs.
  • To elucidate the molecular mechanisms underlying CVB3-induced cardiac malformations.

Main Methods:

  • Pregnant C57Bl/6 mice were infected with CVB3 at embryonic days 5, 7, 9, and 11.
  • Different viral titers were used to assess dose-response effects and viral loads in fetal organs.
  • RNA sequencing, KEGG pathway analysis, and immunohistochemistry were employed to study signaling pathways in affected fetal hearts.

Main Results:

  • CVB3 exposure between embryonic days 7 and 9 resulted in CHDs, including ventricular septal defects (33.6%), noncompaction-like architecture (23.5%), and double-outlet right ventricle (4.4%).
  • A direct correlation was observed between viral titers and CHD severity, with a higher incidence in female fetuses.
  • CVB3-infected fetuses with VSDs showed significantly reduced cardiomyocyte proliferation (50% lower) and altered Hippo, tight junction, TGF-β1, and ECM signaling pathways.

Conclusions:

  • Prenatal CVB3 infection is a causative factor for congenital heart defects.
  • Reduced cardiomyocyte proliferation and subsequent alterations in cardiac architecture and trabeculation are key mechanisms driving CVB3-induced CHDs.
  • Maternal health and placental integrity were unaffected, indicating direct fetal cardiac effects are responsible for CHDs.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
149
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
132
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
200
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.7K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
72
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
152